On 6 December 2012, Aicore begins work to design its product portfolio with one of the world's largest generic pharmaceutical out-licensing companies – Medis, a part of Actavis Group (US).

This partnership makes it possible for Aicore to provide developing markets within the CIS and Eastern Europe with products that meet the Company’s philosophy – to focus on evidence-based medications able to improve the quality of people’s lives.

Choice in the category of products is determined by their significance to the health of our would-be consumers. These are cardiology, endocrinology, and gastroenterology.

Production sites to be used for Aicore’s needs are located exclusively in European countries. This guarantees that all stages of the manufacturing process will correspond to the highest standards of the industry.